Table 5

Association between inflammatory, coagulation, fibrinolysis markers (geometric means with SD) at hospital discharge stratified by diabetes among 1808 subjects discharged alive from the hospital

BiomarkerWith diabetesWithout diabetesp Values
Inflammatory markers (pg/ml)*
TNF4.77 (2.12)4.73 (2.65)0.51
IL-68.67 (6.83)7.41 (5.74)0.03
IL-101 (18.45)1.24 (11.92)0.6
Coagulation markers*
Factor IX activity (%)111.02 (1.30)119.14 (1.25)0.1
Antithrombin (mg/ml)91.77 (1.04)91.50 (1.04)0.87
TAT complexes (μg/ml)4.25 (3.70)3.58 (2.49)0.25
Fibrinolysis markers (ng/ml)*
D-dimer623.79 (3.26)600.86 (2.92)0.67
PAI-13.54 (4.27)3.72 (4.63)0.62
  • * Inflammatory, coagulation and fibrinolysis markers were available at hospital discharge in 1739, 892 and 892 subjects, respectively.

  • IL, interleukin; PAI, plasminogen activator inhibitor; TAT, thrombin–antithrombin; TNF, tumour necrosis factor.